News

Exciting Conference Participation by Skye Bioscience Ahead

Exciting Conference Participation by Skye Bioscience Ahead

Skye Bioscience's Commitment to Healthcare Innovation

Skye Bioscience, Inc. (NASDAQ: SKYE), a pioneering force in the field of biotechnology, is dedicated to exploring new therapeutic pathways targeting obesity and metabolic health disorders. The company is excited to announce its active participation in several upcoming investment and medical conferences that align with its mission of improving patient outcomes through innovative science.

Upcoming Investment Conferences

Cantor Global Healthcare Conference

The first event is the Cantor Global Healthcare Conference where Skye will be hosting a fireside chat. This interactive session is scheduled for September 5 at 8:00 AM ET, combining insightful discussions with one-on-one meetings. Attendees will gain valuable insights into Skye's strategies and future directions.

H.C. Wainwright Global Investment Conference

Following that, on September 8, Skye will present at the H.C. Wainwright Global Investment Conference at 3:30 PM ET. This presentation offers a platform for Skye to showcase its significant advancements in treatment solutions aimed at metabolic conditions, aiming to attract potential investors interested in the biotechnology sector.

Morgan Stanley Global Healthcare Conference

On September 10, Skye will also participate in the Morgan Stanley Global Healthcare Conference with another engaging fireside chat scheduled for 7:00 AM ET. This event will further emphasize the innovative efforts of Skye within the healthcare market and its commitment to advancing therapeutic solutions.

Engagement in Medical and Scientific Conferences

Obesity Science & Innovation Conference

In addition to investment conferences, Skye is proud to contribute to the Obesity Science & Innovation Conference occurring on September 16 at 9:10 AM ET. Here, the company will partake in a keynote panel discussion titled 'Pipeline priorities - exploring leading and emerging targets shaping the future of obesity therapeutics'. This highlights Skye’s commitment to addressing the challenges of obesity through groundbreaking research.

European Association for the Study of Diabetes Annual Meeting

Moreover, Skye will also be presenting at the European Association for the Study of Diabetes (EASD) Annual Meeting on September 19 at 10:15 AM CET. This oral presentation will cover a critical multi-dose study evaluating the safety and tolerability of nimacimab, an innovative antibody aimed at treating metabolic-associated fatty liver disease (MAFLD).

What Makes Skye Unique?

Skye Bioscience is revolutionizing therapy development by focusing on next-generation molecules that modulate G-protein coupled receptors. The company aims to provide improved therapeutic options backed by substantial human proof of mechanism, creating first-in-class treatments tailored to meet patients' needs effectively. The Phase 2a clinical trial they are conducting evaluates the safety and effectiveness of nimacimab in conjunction with a GLP-1R agonist, further solidifying Skye’s position as a leader in metabolic health.

Stay Updated

Interested parties can access live webcasts and detailed information via Skye's official website. As the field of biotechnology evolves, Skye remains dedicated to transparency and communication with its stakeholders, ensuring they stay informed about crucial developments and upcoming initiatives.

CONTACTS

Investor Relations
ir@skyebioscience.com
(858) 410-0266

Media Inquiries
LifeSci Communications, Michael Fitzhugh
mfitzhugh@lifescicomms.com
(628) 234-3889

Frequently Asked Questions

What areas does Skye Bioscience focus on?

Skye Bioscience primarily focuses on therapeutic pathways for obesity and metabolic health disorders through innovative biotechnology solutions.

When is Skye participating in the upcoming conferences?

Skye will participate in various conferences in September, including investment and medical events dedicated to obesity and diabetes.

What is nimacimab?

Nimacimab is a negative allosteric modulating antibody that Skye is currently testing to evaluate its efficacy and safety in treating various metabolic conditions.

How can I get updates from Skye Bioscience?

Updates can be found on Skye's official website where webcasts and other communications are posted.

Where can I find more information about Skye’s clinical trials?

More information regarding Skye’s clinical trials, including the Phase 2a trial for nimacimab, can be found through clinical trial registries or Skye's website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 0

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading
York Space Systems Faces Lawsuit Over IPO Debacle

Updated Category News Views 6

Trouble Brewing in York Space Systems' Orbit Here's the nitty-gritty: York Space Systems (NYSE: YSS)—a company's whose bread was buttered primarily by Uncle Sam—is now facing some serious heat. We're talking about allegations that make you double-check your portfolio and rethink that second helping of whatever Wall Street's serving. The Stakes: From Space to Legal...

Continue Reading
Geek+ Spurs Growth with 35.5% Order Surge and New Model

Updated Category News Views 2

Unexpected Surge in Orders Drives Geek+ It looks like Geek+ isn't just playing around in the robotics sandbox anymore. They're delivering some serious results, reporting a 35.5% increase in new signed orders reaching a whopping RMB2.385 billion for the first half of 2026. That's not chump change, and it injects a healthy dose of optimism into their future performance...

Continue Reading
Rethinking Roof Lifespans for Harsh Michigan Winters

Updated Category News Views 2

Unraveling the Michigan Roof Lifespan Myth When most folks think about the lifespan of their roof, especially in a place like Michigan, they tend to believe those thirty-year warranties plastered all over asphalt shingles. But that's the fairy tale version, folks. Tom Meadows, a roofing expert from Ann Arbor, wants residents to wake up to a chilling reality—Michigan's...

Continue Reading
Salt Lake Temple Celebration Unites the Global Community

Updated Category News Views 3

Gathering in Spirit It’s no small feat when a single event manages to command international attention. This time, the spotlight is on Salt Lake Temple's celebration. It’s not a ticker tape parade on Wall Street, folks, but it sure is gathering eyes like a blue-chip stock on a tear. Loads of people have tuned in, capitalizing on the uplifted spirit and inspiration this...

Continue Reading
Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 0

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Updated Category News Views 4

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Continue Reading
Singlewire's Alert Badge Wins Vision Award in 2026

Updated Category News Views 0

A Badge That Reshapes Communication Safety You might think a simple badge wouldn't earn much fanfare, but here we are — the InformaCast Wearable Alert Badge from Singlewire Software has snagged a prestigious spot at FacilitiesNet's 2026 Vision Awards. What makes this badge special? Well, it's not just a bauble to pin on your lapel; it's a deceptively simple yet powerful...

Continue Reading
BNI Sets Sights on Big Expansion Across Europe

Updated Category News Views 4

BNI Charges Forward: Europe Expansion Strategy This one's got me thinking about how networking giants like BNI are not sitting back comfortably, they're on the move. BNI is going all-in on Europe, making serious waves by locking down new franchise territories in France, Italy, and the UK. It's no small feat—they already have a footprint there with over 35,000 members...

Continue Reading
Vertiv's Bold $1.45B Buyout to Enhance AI Data Centers

Updated Category News Views 6

Vertiv Snatches Up UtilityInnovation Group for $1.45 Billion Throw a stone into the tech sector, and it's bound to hit something about AI or data centers these days. Well, Vertiv Holdings Co. (NYSE: VRT) has made a splash by announcing a meaty $1.45 billion transaction to acquire UtilityInnovation Group (UIG). This move isn't just a bid to dust off the company's resume;...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Partnership for Mental Health in High-Growth Firms

Updated Category News Views 48

Strategic Collaboration for Mental Health Support FTV Capital, an influential growth equity firm, has teamed up with One Mind at Work to introduce a groundbreaking initiative aimed at fostering mental health within high-growth companies. This new partnership celebrates its launch by coinciding with a significant recognition of workplace mental health, emphasizing its...

Continue Reading
Skanska's Major Environmental Lab Renovation Project Unveiled

Updated Category News Views 204

Overview of the Renovation Project Skanska, a renowned construction and development firm, has finalized an agreement with the local environmental department for a significant project focused on upgrading lab facilities. The total investment for this initiative is approximately USD 62 million, translating to about SEK 660 million, a move that reflects Skanska's commitment...

Continue Reading
Olaplex Holdings, Inc. Set for Q2 Financial Results Release

Updated Category News Views 132

Olaplex Holdings, Inc. Financial Results Announcement Olaplex Holdings, Inc. (NASDAQ: OLPX), a leader in the beauty and haircare industry, is gearing up to reveal its second quarter fiscal results. This major announcement is set for a date in early August, just before the market opens. Details of the Financial Release During the anticipated announcement, Olaplex will...

Continue Reading
Dr. Anosh Ahmed Elevates COVID Testing Operations Nationally

Updated Category News Views 166

Dr. Anosh Ahmed Elevates COVID Testing Operations Nationally Chicago serves as a focal point for Dr. Anosh Ahmed's efforts in enhancing COVID-19 testing services. The esteemed physician and entrepreneur is broadening his testing services across the country and internationally, building on his established reputation for delivering high-quality testing solutions infused...

Continue Reading
Sable Offshore Corp. Faces Class Action for Securities Misconduct

Updated Category News Views 112

Understanding the Class Action Against Sable Offshore Corp. Recently, Berger Montague PC, a law firm known for its focus on securities laws, has begun investigating significant claims related to Sable Offshore Corp. (NYSE: SOC). This comes in the wake of a class action lawsuit filed against the company for purported violations of securities regulations. The Allegations...

Continue Reading